Researchers at Sanford-Burnham Medical Research Institute found that the enzyme PKCζ controls the activation of a pro-tumor gene called c-Myc. Normally, PKCζ's alteration keeps c-Myc in check. But PKCζ levels are low in prostate and other cancers, leaving c-Myc free to enhance cell growth and metastasis.
Fuente : http://www.eurekalert.org/pub_releases/2013-04/smr...
Fuente : http://www.eurekalert.org/pub_releases/2013-04/smr...